Endothelin-1 plasma levels in cyclosporine-treated stable renal transplant patients

By Costa C.   Cauduro R.L.   Lhulier F.   Cabral R.D.   Garcia R.G.   Manfro R.C.  

Transplantation Proceedings, Vol. 34, Iss. 2, 2002-03 ,pp. : 487-488

Elsevier

Access to resources Recommend Favorite

Lipoprotein Patterns in Renal Transplant Patients: A Comparison Between FK 506 and Cyclosporine A Patients

By Claesson K.   Mayer A.D.   Squifflet J.-P.   Grabensee B.   Eigler F.W.   Behrend M.   Vanrenterghem Y.   van Hooff J.   Morales J.M.   Johnson R.W.G.   Buchholz B.   Land W.   Forsythe J.L.R.   Neumayer H.-H.   Ericzon B.-G.   Muhlbacher F.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1292-1294

Elsevier

Access to resources Recommend Favorite

A randomized prospective double-blind placebo-controlled study of gallopamil, calcium antagonist of the verapamil type, in stable cyclosporine-treated renal transplant recipients

By Gossmann J.   Mondorf U.   Dietz A.   Kramer W.   Kachel H.-G.   Geiger H.   Scheuermann E.-H.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1767-1770

Elsevier

Access to resources Recommend Favorite

Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients

By Abou-Jaoude M.M.   Irani-Hakime N.   Ghantous I.   Najm R.   Afif C.   Almawi W.Y.  

Transplantation Proceedings, Vol. 35, Iss. 7, 2003-11 ,pp. : 2748-2749

Elsevier

Access to resources Recommend Favorite

Glucose metabolism in heart transplant recipients treated with FK506 or cyclosporine

By Sahar G.   Berman M.   Ben-Gal T.   Sahar E.   Kogan A.   Michowitch R.   Saute M.   Kramer M.   Sagie A.   Shapira Y.   Aravot D.   Vidne B.A.  

Transplantation Proceedings, Vol. 35, Iss. 2, 2003-03 ,pp. : 678-678

Elsevier

Access to resources Recommend Favorite